Clinical Trial Update: Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating vaccine therapy, trastuzumab, and vinorelbine in locally recurrent or metastatic breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• Vaccine therapy
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-09